Does OncuraKit screen the whole body for cancer simultaneously?

Yes — because cancer-associated miRNAs from any location in the body enter the bloodstream and ultimately appear in urine, a single urine-based miRNA screen captures signal from cancers throughout the body. OncuraKit does not target a specific organ; it captures the systemic miRNA signal regardless of tumor location. This is what distinguishes multi-cancer early detection (MCED) tests from traditional single-organ screenings (colonoscopy for colon, mammogram for breast, PSA for prostate). The OncuraKit panel is formally validated against six specific cancer types (prostate, colorectal, pancreatic, ovarian, lung, breast) but the miRNA markers are broadly associated with cancer biology and expected to detect most solid tumors that overexpress these oncomiRs.